{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:04:13Z","timestamp":1791313453778,"version":"4.3.1"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002997","name":"Dutch Kidney Foundation","doi-asserted-by":"publisher","award":["CP10.12"],"award-info":[{"award-number":["CP10.12"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002997","name":"Dutch Kidney Foundation","doi-asserted-by":"publisher","award":["CP15.01"],"award-info":[{"award-number":["CP15.01"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Dutch Government","award":["LSHM15018"],"award-info":[{"award-number":["LSHM15018"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,29]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The epidermal growth factor receptor (EGFR) pathway is involved in kidney tissue repair and growth. Preclinical interventional data and scarce human data have suggested a role for this pathway in the pathophysiology of autosomal dominant polycystic kidney disease (ADPKD), while other data have suggested that its activation is causally linked to repair of damaged kidney tissue. We hypothesize that urinary EGFR ligands, as a reflection of EGFR activity, are associated with kidney function decline in ADPKD in the context of tissue repair following injury, and as the disease progresses as a sign of insufficient repair.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In the present study, we measured the EGFR ligands, EGF and heparin binding-EGF (HB-EGF), in 24-h urine samples of 301 ADPKD patients and 72 age- and sex-matched living kidney donors to dissect the role of the EGFR pathway in ADPKD. During a median follow-up of 2.5 years, the association of urinary EGFR ligand excretion with annual change in estimated glomerular filtration rate (eGFR) and height-adjusted total kidney volume in ADPKD patients was analyzed using mixed-models methods, and the expression of three closely related EGFR family receptors in ADPKD kidney tissue was investigated by immunohistochemistry. Additionally, the effect of reducing renal mass (after kidney donation), was assessed to investigate whether urinary EGF matches this reduction and thus reflects the amount of remaining healthy kidney tissue.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At baseline, urinary HB-EGF did not differ between ADPKD patients and healthy controls (P\u00a0=\u00a0.6), whereas a lower urinary EGF excretion was observed in ADPKD patients [18.6 (11.8\u201327.8)] compared with healthy controls [51.0 (34.9\u201365.4) \u03bcg\/24\u00a0h, P\u00a0&amp;lt;\u00a0.001]. Urinary EGF was positively associated with baseline eGFR (R\u00a0=\u00a00.54, P\u00a0&amp;lt;\u00a0.001) and a lower EGF was strongly associated with a more rapid GFR decline, even when adjusted for ADPKD severity markers (\u03b2 = 1.96, P\u00a0&amp;lt;\u00a0.001), whereas HB-EGF was not. Expression of the EGFR, but not other EGFR-related receptors, was observed in renal cysts but was absent in non-ADPKD kidney tissue. Finally, unilateral nephrectomy resulted in a decrease of 46.4 (\u201363.3 to \u201317.6) % in urinary EGF excretion, alongside a decrease of 35.2\u00a0\u00b1\u00a07.2% in eGFR and 36.8\u00a0\u00b1\u00a06.9% in measured GFR (mGFR), whereas maximal mGFR (measured after dopamine induced hyperperfusion) decreased by 46.1\u00a0\u00b1\u00a07.8% (all P\u00a0&amp;lt;\u00a0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our data suggest that lower urinary EGF excretion may be a valuable novel predictor for kidney function decline in patients with ADPKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ndt\/gfad050","type":"journal-article","created":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T02:46:12Z","timestamp":1678502772000},"page":"2266-2275","source":"Crossref","is-referenced-by-count":9,"title":["The association of urinary epidermal growth factors with ADPKD disease severity and progression"],"prefix":"10.1093","volume":"38","author":[{"given":"Laura R","family":"Harskamp","sequence":"first","affiliation":[{"name":"Department of Nephrology, University Medical Center of Groningen, University of Groningen , Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4558-5236","authenticated-orcid":false,"given":"Maria Vanessa","family":"Perez-Gomez","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz University Hospital and IIS-FJD , Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith E","family":"Heida","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Medical Center of Groningen, University of Groningen , Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerwin E","family":"Engels","sequence":"additional","affiliation":[{"name":"Haemoscan BV, Groningen , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"van Goor","sequence":"additional","affiliation":[{"name":"Department of Pathology and Medical Biology, University Medical Center of Groningen, University of Groningen , Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius C","family":"van den Heuvel","sequence":"additional","affiliation":[{"name":"Department of Pathology and Medical Biology, University Medical Center of Groningen, University of Groningen , Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Streets","sequence":"additional","affiliation":[{"name":"Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Kidney Genetics Group, Academic Nephrology Unit , Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7211-5400","authenticated-orcid":false,"given":"Albert C M","family":"Ong","sequence":"additional","affiliation":[{"name":"Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Kidney Genetics Group, Academic Nephrology Unit , Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9805-9523","authenticated-orcid":false,"given":"Alberto","family":"Ortiz","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz University Hospital and IIS-FJD , Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3223-0906","authenticated-orcid":false,"given":"Ron T","family":"Gansevoort","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Medical Center of Groningen, University of Groningen , Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the DIPAK Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J P H","family":"Drenth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J W","family":"de Fijter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M D A","family":"van Gastel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Losekoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D J M","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F W","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Wetzels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Zietse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,3,13]]},"reference":[{"key":"2023092902503615300_bib1","first-page":"1356","article-title":"Prevalence of autosomal dominant polycystic kidney disease in the European Union","volume":"32","author":"Willey","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"2023092902503615300_bib2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/HYPERTENSIONAHA.108.113860","article-title":"Epidermal growth factor receptor signaling in the kidney: key roles in physiology and disease","volume":"52","author":"Melenhorst","year":"2008","journal-title":"Hypertension"},{"key":"2023092902503615300_bib3","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/nrneph.2016.91","article-title":"The epidermal growth factor receptor pathway in chronic kidney diseases","volume":"12","author":"Harskamp","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"2023092902503615300_bib4","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.bbadis.2006.04.006","article-title":"Inhibition of HER-2(neu\/ErbB2) restores normal function and structure to polycystic kidney disease (PKD) epithelia","volume":"1762","author":"Wilson","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"2023092902503615300_bib5","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/ki.1992.184","article-title":"In vitro formation and expansion of cysts derived from human renal cortex epithelial cells","volume":"41","author":"Neufeld","year":"1992","journal-title":"Kidney Int"},{"key":"2023092902503615300_bib6","first-page":"386","article-title":"Renal cysts in transgenic mice expressing transforming growth factor-alpha","volume":"124","author":"Lowden","year":"1994","journal-title":"J Lab Clin Med"},{"key":"2023092902503615300_bib7","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2215\/CJN.09941014","article-title":"Urinary EGF receptor ligand excretion in patients with autosomal dominant polycystic kidney disease and response to tolvaptan","volume":"10","author":"Harskamp","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"2023092902503615300_bib8","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1053\/j.ajkd.2013.10.011","article-title":"Rationale and design of the DIPAK 1 study: a randomized controlled clinical trial assessing the efficacy of lanreotide to halt disease progression in autosomal dominant polycystic kidney disease","volume":"63","author":"Meijer","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"2023092902503615300_bib9","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1001\/jama.2018.15870","article-title":"Effect of lanreotide on kidney function in patients with autosomal dominant polycystic kidney disease: the DIPAK 1 randomized clinical trial","volume":"320","author":"Meijer","year":"2018","journal-title":"JAMA"},{"key":"2023092902503615300_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1681\/ASN.2008050507","article-title":"Unified criteria for ultrasonographic diagnosis of ADPKD","volume":"20","author":"Pei","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2023092902503615300_bib11","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2023092902503615300_bib12","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s00261-017-1285-2","article-title":"T1 vs. T2 weighted magnetic resonance imaging to assess total kidney volume in patients with autosomal dominant polycystic kidney disease","volume":"43","author":"van Gastel","year":"2018","journal-title":"Abdom Radiol (NY)"},{"key":"2023092902503615300_bib13","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1681\/ASN.2013101138","article-title":"Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials","volume":"26","author":"Irazabal","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2023092902503615300_bib14","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1681\/ASN.2006121387","article-title":"Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease","volume":"18","author":"Rossetti","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2023092902503615300_bib15","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.kint.2019.08.038","article-title":"Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease","volume":"97","author":"Hopp","year":"2020","journal-title":"Kidney Int"},{"key":"2023092902503615300_bib16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1159\/000502999","article-title":"Rapid progression of autosomal dominant polycystic kidney disease: urinary biomarkers as predictors","volume":"50","author":"Messchendorp","year":"2019","journal-title":"Am J Nephrol"},{"key":"2023092902503615300_bib17","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1172\/JCI2071","article-title":"Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease","volume":"101","author":"Richards","year":"1998","journal-title":"J Clin Invest"},{"key":"2023092902503615300_bib18","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1046\/j.1523-1755.2003.00256.x","article-title":"EGF receptor tyrosine kinase inhibition attenuates the development of PKD in han:SPRD rats","volume":"64","author":"Torres","year":"2003","journal-title":"Kidney Int"},{"key":"2023092902503615300_bib19","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1046\/j.1523-1755.2003.00232.x","article-title":"Combination treatment of PKD utilizing dual inhibition of EGF-receptor activity and ligand bioavailability","volume":"64","author":"Sweeney","year":"2003","journal-title":"Kidney Int"},{"key":"2023092902503615300_bib20","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/nm.2491","article-title":"Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis","volume":"17","author":"Boll\u00e9e","year":"2011","journal-title":"Nat Med"},{"key":"2023092902503615300_bib21","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1681\/ASN.2016111232","article-title":"Bosutinib versus placebo for autosomal dominant polycystic kidney disease","volume":"28","author":"Tesar","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2023092902503615300_bib22","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.kint.2016.01.015","article-title":"Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes","volume":"89","author":"Betz","year":"2016","journal-title":"Kidney Int"},{"key":"2023092902503615300_bib23","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/ki.2012.435","article-title":"Role of epidermal growth factor receptor in acute and chronic kidney injury","volume":"83","author":"Tang","year":"2013","journal-title":"Kidney Int"},{"key":"2023092902503615300_bib24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/sj.ki.5002621","article-title":"The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy","volume":"73","author":"Torres","year":"2008","journal-title":"Kidney Int"},{"key":"2023092902503615300_bib25","doi-asserted-by":"crossref","first-page":"316ra193","DOI":"10.1126\/scitranslmed.aac7071","article-title":"Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker","volume":"7","author":"Ju","year":"2015","journal-title":"Sci Transl Med"},{"key":"2023092902503615300_bib26","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s00467-018-3988-1","article-title":"Urinary epidermal growth factor as a prognostic marker for the progression of alport syndrome in children","volume":"33","author":"Li","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"2023092902503615300_bib27","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.kint.2019.01.035","article-title":"Low levels of urinary epidermal growth factor predict chronic kidney disease progression in children","volume":"96","author":"Azukaitis","year":"2019","journal-title":"Kidney Int"},{"key":"2023092902503615300_bib28","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1006\/dbio.1995.1164","article-title":"Epidermal growth factor ameliorates autosomal recessive polycystic kidney disease in mice","volume":"169","author":"Gattone","year":"1995","journal-title":"Dev Biol"},{"key":"2023092902503615300_bib29","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1523-1755.2003.00185.x","article-title":"Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): the consortium for radiologic imaging studies of polycystic kidney disease (CRISP) cohort","volume":"64","author":"Chapman","year":"2003","journal-title":"Kidney Int"},{"key":"2023092902503615300_bib30","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.kint.2017.09.027","article-title":"Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in autosomal dominant polycystic kidney disease","volume":"93","author":"Yu","year":"2018","journal-title":"Kidney Int"},{"key":"2023092902503615300_bib31","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","author":"Serra","year":"2010","journal-title":"N Engl J Med"},{"key":"2023092902503615300_bib32","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/ndt\/gfx043","article-title":"Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 trial","volume":"33","author":"Torres","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"2023092902503615300_bib33","first-page":"F632","article-title":"In situ hybridization of prepro-epidermal growth factor mRNA in the mouse kidney","volume":"256","author":"Salido","year":"1989","journal-title":"Am J Physiol"},{"key":"2023092902503615300_bib34","doi-asserted-by":"crossref","first-page":"e54136","DOI":"10.1371\/journal.pone.0054136","article-title":"Molecular determinants of epidermal growth factor binding: a molecular dynamics study","volume":"8","author":"Sanders","year":"2013","journal-title":"PLoS One"},{"key":"2023092902503615300_bib35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0065-230X(08)60784-8","article-title":"Biochemical and clinical implications of the ErbB\/HER signaling network of growth factor receptors","volume":"77","author":"Klapper","year":"2000","journal-title":"Adv Cancer Res"},{"key":"2023092902503615300_bib36","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.cell.2017.09.017","article-title":"EGFR ligands differentially stabilize receptor dimers to specify signaling kinetics","volume":"171","author":"Freed","year":"2017","journal-title":"Cell"},{"key":"2023092902503615300_bib37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2353\/ajpath.2006.050342","article-title":"Defining a link with autosomal-dominant polycystic kidney disease in mice with congenitally low expression of Pkd1","volume":"168","author":"Jiang","year":"2006","journal-title":"Am J Pathol"},{"key":"2023092902503615300_bib38","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1172\/JCI114359","article-title":"Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure","volume":"84","author":"Humes","year":"1989","journal-title":"J Clin Invest"},{"key":"2023092902503615300_bib39","doi-asserted-by":"crossref","first-page":"C1843","DOI":"10.1152\/ajpcell.00370.2007","article-title":"Opposing roles of EGF in IFN-alpha-induced epithelial barrier destabilization and tissue repair","volume":"293","author":"Lechner","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"2023092902503615300_bib40","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.2215\/CJN.08761209","article-title":"Renal function equations before and after living kidney donation: a within-individual comparison of performance at different levels of renal function","volume":"5","author":"Tent","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2023092902503615300_bib41","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3109\/0886022X.2010.486496","article-title":"Simultaneous monitoring of multiple urinary cytokines may predict renal and patient outcome in ischemic AKI","volume":"32","author":"Kwon","year":"2010","journal-title":"Ren Fail"},{"key":"2023092902503615300_bib42","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ekir.2017.01.003","article-title":"Total kidney volume is a prognostic biomarker of renal function decline and progression to end-stage renal disease in patients with autosomal dominant polycystic kidney disease","volume":"2","author":"Perrone","year":"2017","journal-title":"Kidney Int Rep"},{"key":"2023092902503615300_bib43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/08977194.2014.952410","article-title":"EGFR signaling patterns are regulated by its different ligands","volume":"32","author":"Knudsen","year":"2014","journal-title":"Growth Factors"},{"key":"2023092902503615300_bib44","doi-asserted-by":"crossref","first-page":"100872","DOI":"10.1016\/j.jbc.2021.100872","article-title":"Binding of single-mutant epidermal growth factor (EGF) ligands alters the stability of the EGF receptor dimer and promotes growth signaling","volume":"297","author":"Pascarelli","year":"2021","journal-title":"J Biol Chem"},{"key":"2023092902503615300_bib45","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.1074\/jbc.M115.710087","article-title":"Different epidermal growth factor receptor (EGFR) agonists produce unique signatures for the recruitment of downstream signaling proteins","volume":"291","author":"Ronan","year":"2016","journal-title":"J Biol Chem"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfad050\/51094530\/gfad050.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/38\/10\/2266\/51786528\/gfad050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/38\/10\/2266\/51786528\/gfad050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T22:51:51Z","timestamp":1695941511000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/38\/10\/2266\/7076886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,13]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,3,13]]},"published-print":{"date-parts":[[2023,9,29]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfad050","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,10]]},"published":{"date-parts":[[2023,3,13]]}}}